gaining an advantage over nsclc: how to achieve the greatest benefit with immunotherapy
Published 2 years ago • 546 plays • Length 1:44:45Download video MP4
Download video MP3
Similar videos
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
1:10:25
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
1:09:47
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
51:59
facilitating progress in the treatment of sclc
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
21:36
are we closer to a cure with perioperative immunotherapy in resectable nsclc?
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:27:28
the continuing success story of immunotherapy in nsclc
-
1:03:14
changing the game for es-sclc with immunotherapy and multidisciplinary collaboration
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
1:25:42
navigating immunotherapies and combinations in the search for the best strategy for each patient
-
47:55
advanced gastroesophageal cancers: maximizing the benefits of novel immunotherapy approaches
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
1:06:25
watch drs. socinski & nieva discuss ncslc immunotherapy - visit: https://bit.ly/3k7g96t